75
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effect of Lateral Lymph Nodes Without Malignant Characteristics on the Prognosis of Patients with Rectal Cancer

, , , , , , , , & ORCID Icon show all
Pages 3509-3518 | Received 10 May 2022, Accepted 08 Sep 2022, Published online: 01 Nov 2022

References

  • Nakamura T , WatanabeM. Lateral lymph node dissection for lower rectal cancer. World J. Surg.37(8), 1808–1813 (2013).
  • Sato H , MaedaK, MarutaM. Prognostic significance of lateral lymph node dissection in node positive low rectal carcinoma. Int. J. Colorectal. Dis.26(7), 881–889 (2011).
  • Kim TG , ParkW, ChoiDHet al. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients. Int. J. Colorectal. Dis.29(2), 193–200 (2014).
  • Kim TH , JeongSY, ChoiDHet al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann. Surg. Oncol.15(3), 729–737 (2008).
  • Kim MJ , KimTH, KimDYet al. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? J. Surg. Oncol. 111(4), 459–464 (2015).
  • Fujita S , MizusawaJ, KanemitsuYet al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann. Surg.266(2), 201–207 (2017).
  • Kodeda K , HolmbergE, JorgrenF, NordgrenS, LindmarkG. Rectal washout and local recurrence of cancer after anterior resection. Br. J. Surg.97(10), 1589–1597 (2010).
  • Kusters M , UeharaK, VeldeC, MoriyaY. Is there any reason to still consider lateral lymph node dissection in rectal cancer? Rationale and technique. Clin. Colon Rectal Surg.30(5), 346–356 (2017).
  • Glynne-Jones R , WyrwiczL, TiretEet al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol.28(Suppl. 4), iv22–iv40 (2017).
  • Watanabe T , MuroK, AjiokaYet al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int. J. Clin. Oncol.23(1), 1–34 (2018).
  • Akiyoshi T , WatanabeT, MiyataSet al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann. Surg. 255(6), 1129–1134 (2012).
  • Matsuoka H , NakamuraA, MasakiTet al. Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res.27(5B), 3529–3533 (2007).
  • Matsuoka H , MasakiT, SugiyamaM, AtomiY, OhkuraY, SakamotoA. Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma. Langenbecks Arch. Surg.392(5), 543–547 (2007).
  • Akiyoshi T , MatsuedaK, HiratsukaMet al. Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer. Ann. Surg. Oncol.22(Suppl. 3), S614–S620 (2015).
  • Brown G , RichardsCJ, BourneMWet al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology227(2), 371–377 (2003).
  • Sun RJ , WangL, LiXTet al. Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer. J. Cancer Res. Clin. Oncol.146(3), 739–748 (2020).
  • Fujita S , AkasuT, MizusawaJet al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol.13(6), 616–621 (2012).
  • Hojo K , SawadaT, MoriyaY. An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis. Colon Rectum32(2), 128–133 (1989).
  • Sugihara K , MoriyaY, AkasuT, FujitaS. Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome. Cancer78(9), 1871–1880 (1996).
  • Quadros CA , FalcaoMF, CarvalhoME, LadeiaPA, LopesA. Metastases to retroperitoneal or lateral pelvic lymph nodes indicated unfavorable survival and high pelvic recurrence rates in a cohort of 102 patients with low rectal adenocarcinoma. J. Surg. Oncol.106(6), 653–658 (2012).
  • Hoshino N , MurakamiK, HidaK, SakamotoT, SakaiY. Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis. Int. J. Clin. Oncol.24(1), 46–52 (2019).
  • Schmoll HJ , Van CutsemE, SteinAet al. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann. Oncol.23(10), 2479–2516 (2012).
  • Ishibe A , OtaM, WatanabeJet al. Prediction of lateral pelvic lymph-node metastasis in low rectal cancer by magnetic resonance imaging. World J. Surg.40(4), 995–1001 (2016).
  • Akiyoshi T , UenoM, MatsuedaKet al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann. Surg. Oncol.21(1), 189–196 (2014).
  • Sapci I , DelaneyCP, LiskaDet al. Oncological outcomes of patients with locally advanced rectal cancer and lateral pelvic lymph node involvement. J. Gastrointest. Surg.23(7), 1454–1460 (2019).
  • Kanemitsu Y , KomoriK, ShidaDet al. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: a comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Surgery162(2), 303–314 (2017).
  • Duong TT , AnHH, QuocLV, SonVN, DucNM. Laparoscopic lateral pelvic lymph node dissection for advanced lower rectal cancer: a preliminary Vietnamese study. Med. Arch.75(4), 297–301 (2021).
  • Group MS , ShihabOC, TaylorFet al. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br. J. Surg.98(12), 1798–1804 (2011).
  • Ogura A , KonishiT, CunninghamCet al. Neoadjuvant (chemo) radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J. Clin. Oncol.37(1), 33–43 (2019).
  • Schaap DP , OguraA, NederendJet al. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer. Br. J. Surg.105(13), 1844–1852 (2018).
  • Kim NK , KimMJ, ParkJK, ParkSI, MinJS. Preoperative staging of rectal cancer with MRI: accuracy and clinical usefulness. Ann. Surg. Oncol.7(10), 732–737 (2000).
  • Zhuang Z , ZhangY, WeiM, YangX, WangZ. Magnetic resonance imaging evaluation of the accuracy of various lymph node staging criteria in rectal cancer: a systematic review and meta-analysis. Front. Oncol.11, 709070 (2021).
  • Ishihara S , KawaiK, TanakaTet al. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Tech. Coloproctol.22(5), 347–354 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.